Earnings summaries and quarterly performance for OXBRIDGE RE HOLDINGS.
Executive leadership at OXBRIDGE RE HOLDINGS.
Board of directors at OXBRIDGE RE HOLDINGS.
Research analysts who have asked questions during OXBRIDGE RE HOLDINGS earnings calls.
Recent press releases and 8-K filings for OXBR.
Oxbridge Reports Q3 2025 Financials and Advances Web3 Reinsurance Initiatives
OXBR
Earnings
New Projects/Investments
Dividends
- Oxbridge reported a net income of $187,000 or $0.02 per basic and diluted share for the third quarter ended September 30, 2025, a significant improvement from a net loss of $540,000 or $0.09 loss per share in the prior year's quarter.
- Total revenue for Q3 2025 increased to $645,000 from $205,000 in Q3 2024, though total expenses also rose to $815,000 from $490,000, primarily due to higher professional, personnel, and legal costs.
- The company's Web3 subsidiary, AssurancePlus, is advancing tokenized reinsurance securities, with its 2025-2026 tokenized reinsurance contracts, EDA CAC-RE and ZETA CAC-RE, on pace to achieve 25% and 42% returns, respectively.
- Oxbridge is evaluating a move towards regular dividend payouts for its security-backed CAC-RE tokens, shifting from a purely annual payout model to meet Web3 market demand and investor preference.
Nov 6, 2025, 9:30 PM
Oxbridge Re Reports Q3 2025 Results and Provides 2025-2026 Contract Performance Updates
OXBR
Earnings
New Projects/Investments
Dividends
- Oxbridge Re Holdings reported a net loss of $187,000 (or ($0.02) basic and diluted loss per share) for the quarter ended September 30, 2025, an improvement from a net loss of $540,000 (or ($0.09) basic and diluted loss per share) for the same period in 2024. For the nine months ended September 30, 2025, the net loss was $2.19 million (or ($0.30) basic and diluted loss per share), compared to $2.27 million (or ($0.37) basic and diluted loss per share) for the prior year period.
- Net premiums earned for the quarter ended September 30, 2025, decreased to $555,000 from $595,000 for the prior year quarter, while for the nine months ended September 30, 2025, they increased to $1.73 million from $1.71 million for the prior year period.
- The company's SurancePlus Balanced Yield Token (EtaCat Re) is tracking an approximate 25% annual return, exceeding its 20% target, and the High Yield Token (ZetaCat Re) remains on track to meet its 42% target for 2025-2026.
- The combined ratio for the quarter ended September 30, 2025, increased to 146.8% from 83.7% in the prior year quarter, and for the nine months ended September 30, 2025, it increased to 288.6% from 98% in the prior year period. This increase was primarily due to higher general and administrative expenses and losses incurred, including a 132.4% loss ratio for the nine-month period due to a full limit loss on a reinsurance contract affected by Hurricane Milton.
- Oxbridge Re is considering introducing regular dividend payouts on its security-backed CatRe tokens, moving away from a purely annual payout model.
Nov 6, 2025, 9:13 PM
Oxbridge Re Holdings Limited Reports Q3 2025 Results and SurancePlus Performance Update
OXBR
Earnings
New Projects/Investments
Guidance Update
- Oxbridge Re Holdings Limited reported a net loss of $187,000 (or ($0.02) basic and diluted loss per share) for the three months ended September 30, 2025, an improvement from a net loss of $540,000 (or ($0.09) basic and diluted loss per share) in the prior year period, primarily due to a decrease in unrealized loss on other investments.
- Net premiums earned for Q3 2025 decreased to $555,000 from $595,000 for the quarter ended September 30, 2024, while total expenses increased to $815,000 from $498,000, resulting in an expense ratio of 146.8%.
- For the nine months ended September 30, 2025, the loss ratio increased to 132.4% due to a full limit loss on one reinsurance contract affected by Hurricane Milton, and the combined ratio rose to 288.6%.
- The SurancePlus Balanced Yield Token (EtaCat Re) is tracking an approximate 25% annual return, exceeding its 20% target, and the High Yield Token (ZetaCat Re) remains on track for its 42% target. The company is also considering introducing regular dividend payouts on its security-backed CatRe tokens.
- As of September 30, 2025, restricted cash and cash equivalents increased by $1.28 million (21.7%) to $7.18 million from $5.9 million as of December 31, 2024.
Nov 6, 2025, 9:04 PM
Oxbridge Re Holdings Provides Performance Update on 2025/2026 Tokenized Reinsurance Offerings
OXBR
New Projects/Investments
Guidance Update
- Oxbridge Re Holdings (NASDAQ: OXBR) and its subsidiary SurancePlus announced an update on the performance of their 2025/2026 tokenized reinsurance securities.
- The EtaCat Re – Balanced Yield Token is tracking 25%, exceeding its targeted 20% return.
- The ZetaCat Re – High Yield Token is on track to achieve its targeted 42% return.
- Jay Madhu, CEO of Oxbridge, commented that these results demonstrate the company's ability to deliver high-yield, uncorrelated returns.
Nov 3, 2025, 2:00 PM
Oxbridge Re Holdings Files Prospectus Supplement for Share Sale
OXBR
- On September 16, 2025, Oxbridge Re Holdings Limited filed a prospectus supplement permitting the sale of $2,021,889 of its ordinary shares through an equity distribution agreement with Maxim Group LLC.
- This equity distribution agreement (EDA) allows for the issuance and sale of ordinary shares for an aggregate amount of up to US$5,000,000.
- As of the filing date, the company had offered and sold $4.58 million in ordinary shares during the prior 12 months.
- Following this, $1,672,714 of ordinary shares remain available to be sold pursuant to the prospectus supplement.
Sep 16, 2025, 9:00 PM
Quarterly earnings call transcripts for OXBRIDGE RE HOLDINGS.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more